Related Experiment Video

Updated: Aug 17, 2026

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

[Serum eosinophil cationic protein (ECP) and major basic protein (MBP) levels in patients prepared for asthma attack]

M Miyoshi1, T Sakurai, S Kodama

  • 1Department of Pediatrics, Himeji Red Cross Hospital.

Arerugi = [Allergy]
|December 1, 1992
PubMed

Insights

Serum eosinophil cationic protein (ECP) levels may indicate an increased risk of asthma attacks in children. Higher ECP levels were observed in children who experienced asthma attacks during a home-stay loading test.

Area of Science:

  • Allergy and immunology
  • Pediatric respiratory medicine
  • Biomarker research

Context:

  • Asthma attacks in children can be unpredictable.
  • Identifying reliable biomarkers for predicting asthma exacerbations is crucial for timely intervention.
  • Previous studies have explored various markers, but a definitive predictor remains elusive.

Purpose:

  • To investigate the correlation between serum eosinophil cationic protein (ECP) levels, serum eosinophil major basic protein (MBP) levels, and blood eosinophil counts (Eo) with the occurrence of asthma attacks in severely asthmatic children.
  • To determine if these markers can predict impending asthma attacks before or shortly after a home-stay loading test.

Summary:

  • Serum ECP levels were significantly higher in severely asthmatic children who experienced asthma attacks during a home-stay loading test compared to those who did not.
  • A notable increase in serum ECP levels was also observed in patients whose asthma attacks began within 12 hours of returning home.
  • No significant correlations were found between serum MBP levels or peripheral eosinophil counts and the occurrence or timing of asthma attacks.

Impact:

  • Serum ECP may serve as a valuable predictive biomarker for asthma attacks in pediatric patients.
  • This finding could lead to improved monitoring and proactive management strategies for children with severe asthma.
  • Further research is warranted to validate these findings in larger cohorts and explore the clinical utility of serum ECP monitoring.

More Related Videos

Methodology for Sputum Induction and Laboratory Processing13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Basophil Activation Test for Allergy Diagnosis07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...